Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 42(1): 27-32, Jan.-Feb. 2020. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1055350

RESUMO

Objective: Patients with schizophrenia have visual processing impairments. The main findings from the literature indicate that these deficits may be related to differences in paradigms, medications, and illness duration. This study is part of a large-scale study investigating visual sensitivity in schizophrenia. Here we aimed to investigate the combined effects of illness duration and antipsychotic use on contrast sensitivity function. Methods: Data were collected from 50 healthy controls and 50 outpatients with schizophrenia (classified according to illness duration and medication type) aged 20-45 years old. The contrast sensitivity function was measured for spatial frequencies ranging from 0.2 to 20 cycles per degree using linear sine-wave gratings. Results: Patients with an illness duration > 5 years had more pronounced deficits. Differences in the combined effects of illness duration and antipsychotic use were marked in patients on typical antipsychotics who had been ill > 10 years. No significant differences were found between typical and atypical antipsychotics in patients with an illness duration < 5 years. Conclusion: Visual impairment was related to both long illness duration and medication type. These results should be tested in further studies to investigate pharmacological mechanisms.


Assuntos
Humanos , Masculino , Feminino , Adulto , Adulto Jovem , Esquizofrenia/tratamento farmacológico , Antipsicóticos/efeitos adversos , Transtornos da Visão/induzido quimicamente , Escalas de Graduação Psiquiátrica , Esquizofrenia/complicações , Fatores de Tempo , Visão Ocular/efeitos dos fármacos , Sensibilidades de Contraste/efeitos dos fármacos , Estudos de Casos e Controles , Clorpromazina/efeitos adversos , Resultado do Tratamento , Pessoa de Meia-Idade
2.
Braz J Psychiatry ; 42(1): 27-32, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31269094

RESUMO

OBJECTIVE: Patients with schizophrenia have visual processing impairments. The main findings from the literature indicate that these deficits may be related to differences in paradigms, medications, and illness duration. This study is part of a large-scale study investigating visual sensitivity in schizophrenia. Here we aimed to investigate the combined effects of illness duration and antipsychotic use on contrast sensitivity function. METHODS: Data were collected from 50 healthy controls and 50 outpatients with schizophrenia (classified according to illness duration and medication type) aged 20-45 years old. The contrast sensitivity function was measured for spatial frequencies ranging from 0.2 to 20 cycles per degree using linear sine-wave gratings. RESULTS: Patients with an illness duration > 5 years had more pronounced deficits. Differences in the combined effects of illness duration and antipsychotic use were marked in patients on typical antipsychotics who had been ill > 10 years. No significant differences were found between typical and atypical antipsychotics in patients with an illness duration < 5 years. CONCLUSION: Visual impairment was related to both long illness duration and medication type. These results should be tested in further studies to investigate pharmacological mechanisms.


Assuntos
Antipsicóticos/efeitos adversos , Esquizofrenia/tratamento farmacológico , Transtornos da Visão/induzido quimicamente , Adulto , Estudos de Casos e Controles , Clorpromazina/efeitos adversos , Sensibilidades de Contraste/efeitos dos fármacos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Escalas de Graduação Psiquiátrica , Esquizofrenia/complicações , Fatores de Tempo , Resultado do Tratamento , Visão Ocular/efeitos dos fármacos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA